Irritable bowel syndrome: classification, dietary approach, pharmacological and psychological treatments

Authors

  • Khalid Mohammed Al Ghamdi Department of Gastroenterology, King Fahad General Hospital, Jeddah, Saudi Arabia
  • Mohammed Abdullah Alghamdi Department of Internal Medicine, Hera Hospital, Mecca, Saudi Arabia
  • Huda Ali Alqahtani Department of Family Medicine, Wasat Abha Primary Healthcare Center, Abha, Saudi Arabia
  • Sari Ateeq Alsulami Department of Intensive Care Unit, Rabigh General Hospital, Mecca, Saudi Arabia
  • Ali Mesfer Alghamdi Pharmacy Department, Prince Mansour Military Hospital, Taif, Saudi Arabia
  • Abdullah Ahmed Aljohani Community Pharmacy, King Fahad General Hospital, Jeddah, Saudi Arabia
  • Mohamed Awad Alqarni 7Primary Healthcare, Ministry of Health, Sarat Abidah, Saudi Arabia
  • Latifah Ibrahim Al-Mulhim Dhahran Long Term Care Hospital, Dhahran, Saudi Arabia
  • Nidhal Ibrahim Bahadir Primary Health Care, Ministry of Health, Medina, Saudi Arabia
  • Fahad Ibrahim Aljdibi Department of Emergency Medicine, East Jeddah Hospital, Jeddah, Saudi Arabia
  • Ahmed Mohamed Ebrahim General Physician, Al Amal Hospital, Buri, Bahrain

DOI:

https://doi.org/10.18203/2394-6040.ijcmph20233863

Keywords:

Dietary management, Irritable bowel syndrome, Pharmacological treatment, Psychological therapy, Symptom classification

Abstract

Irritable bowel syndrome is a long-lasting disorder that affects a significant number of people worldwide. This comprehensive study explores the complexities of IBS, thoroughly investigating its classification, signs, and various treatment approaches. It emphasizes the nature of IBS symptoms, highlighting the importance of tailored treatment strategies that consider adjustments, medications, and psychological therapies. The study recognizes that each patient responds differently to treatments, underscoring the need for care. By shedding light on the nature of IBS and acknowledging experiences, this research aims to provide an updated and evidence-based understanding of managing IBS. The significance of an approach is emphasized, recognizing how health, psychological well-being, and lifestyle factors are interconnected in IBS. Alongside medication for symptom relief and therapies addressing aspects, dietary modifications play a vital role in improving patient outcomes and overall quality of life. This integrated strategy aims to address IBS's impact on health and overall well-being. In summary, this study provides information for healthcare professionals and researchers to provide an understanding of the complexities of IBS and advocate for a personalized and evidence-based approach to its treatment.

 

References

Saha L. Irritable bowel syndrome: pathogenesis, diagnosis, treatment, and evidence-based medicine. World J Gastroenterol. 2014;20(22):6759-73.

Kopczyńska M, Mokros Ł, Pietras T, Małecka-Panas E. Quality of life and depression in patients with irritable bowel syndrome. Przeglad Gastroenterol. 2018;13(2):102-8.

Clapp M, Aurora N, Herrera L, Bhatia M, Wilen E, Wakefield S. Gut microbiota's effect on mental health: The gut-brain axis. Clin Pract. 2017;7(4):987.

Canavan C, West J, Card T. The epidemiology of irritable bowel syndrome. Clin Epidemiol. 2014;6:71-80.

Costanian C, Tamim H, Assaad S. Prevalence and factors associated with irritable bowel syndrome among university students in Lebanon: findings from a cross-sectional study. World J Gastroenterol. 2015; 21(12):3628-35.

Ballou S, Keefer L. Psychological Interventions for Irritable Bowel Syndrome and Inflammatory Bowel Diseases. Clini Translat Gastroenterol. 2017;8(1): e214.

Naliboff BD, Fresé MP, Rapgay L. Mind/Body psychological treatments for irritable bowel syndrome. Evid Complement Alt Med. 2008;5(1):41-50.

Aziz MNM, Kumar J, Muhammad Nawawi KN, Raja Ali RA, Mokhtar NM. Irritable Bowel Syndrome, Depression, and Neurodegeneration: A Bidirectional Communication from Gut to Brain. Nutrients. 2021; 13(9):23-9.

Karl JP, Hatch AM, Arcidiacono SM. Effects of Psychological, Environmental and Physical Stressors on the Gut Microbiota. Front Microbiol. 2018;9:2013.

Banerjee A, Sarkhel S, Sarkar R, Dhali GK. Anxiety and Depression in Irritable Bowel Syndrome. Indian J Psychol Med. 2017;39(6):741-5.

Fond G, Loundou A, Hamdani N. Anxiety and depression comorbidities in irritable bowel syndrome (IBS): a systematic review and meta-analysis. Eur Arch Psychiatr Clin Neurosci. 2014;264(8):651-60.

Shaikh SD, Sun N, Canakis A, Park WY, Weber HC. Irritable Bowel Syndrome and the Gut Microbiome: A Comprehensive Review. J Clin Med. 2023;12(7):23-9.

Kinsinger SW. Cognitive-behavioral therapy for patients with irritable bowel syndrome: current insights. Psychol Res Behav Manage. 2017;10:231-7.

Muscatello MR, Bruno A, Mento C, Pandolfo G, Zoccali RA. Personality traits and emotional patterns in irritable bowel syndrome. World J Gastroenterol. 2016;22(28):6402-15.

Jiang X, Locke GR, Choung RS, Zinsmeister AR, Schleck CD, Talley NJ. Prevalence and risk factors for abdominal bloating and visible distention: a population-based study. Gut. 2008;57(6):756-3.

Heidelbaugh J, Martinez de Andino N, Pineles D, Poppers DM. Diagnosing Constipation Spectrum Disorders in a Primary Care Setting. J Clin Med. 2021;10(5):23-9.

Bharucha AE, Wald A. Chronic Constipation. Mayo Clin Proc. 2019;94(11):2340-57.

Magge S, Lembo A. Low-FODMAP Diet for Treatment of Irritable Bowel Syndrome. Gastroenterol Hepatol. 2012;8(11):739-45.

Sarvepalli SS, Vemula SL, Aramadaka S, et al. Digesting the Impact of Diet on Irritable Bowel Syndrome (IBS): Exploring Solutions for Controlling IBS. Cureus. 2023;15(9):e45279.

Bundeff AW, Woodis CB. Selective serotonin reuptake inhibitors for the treatment of irritable bowel syndrome. Ann Pharmacother. 2014;48(6):777-84.

Gros M, Gros B, Mesonero JE, Latorre E. Neurotransmitter Dysfunction in Irritable Bowel Syndrome: Emerging Approaches for Management. J Clin Med. 2021;10(15):23-9.

Fayyaz M, Lackner JM. Serotonin receptor modulators in the treatment of irritable bowel syndrome. Ther Clin Risk Manag. 2008;4(1):41-8.

Khanna R, MacDonald JK, Levesque BG. Peppermint oil for the treatment of irritable bowel syndrome: a systematic review and meta-analysis. J Clin Gastroenterol. 2014; 48(6):505-12.

Downloads

Published

2023-12-20

How to Cite

Ghamdi, K. M. A., Alghamdi, M. A., Alqahtani, H. A., Alsulami, S. A., Alghamdi, A. M., Aljohani, A. A., Alqarni, M. A., Al-Mulhim, L. I., Bahadir, N. I., Aljdibi, F. I., & Ebrahim, A. M. (2023). Irritable bowel syndrome: classification, dietary approach, pharmacological and psychological treatments. International Journal Of Community Medicine And Public Health, 11(1), 480–484. https://doi.org/10.18203/2394-6040.ijcmph20233863

Issue

Vol. 11 No. 1 (2024): January 2024

Section

Review Articles